CLINICAL: Snores and scales: Tackling obesity and OSA
Tracks
Track 2
| Saturday, October 11, 2025 |
| 11:00 AM - 12:30 PM |
Details
Obesity is a major risk factor for obstructive sleep apnea (OSA), contributing to airway obstruction, reduced lung function, and increased disease severity. This session will explore the complex relationship between obesity and OSA, highlighting the physiological mechanisms linking excess weight to sleep-disordered breathing.
Attendees will gain insights into the impact on cardiovascular health, metabolic disorders, and quality of life. The session will also review the latest advancements in weight management strategies, including lifestyle interventions, bariatric surgery, and pharmacological treatments such as GLP-1 receptor agonists.
Speaker
Danny Eckert
OSA and obesity: Nuts and bolts (epidemiology and endotypes/phenotypes)
11:00 AM - 11:20 AMBiography
Samantha Hocking
Obesity and weight loss: Endocrinologist/obesity physician point of view
11:20 AM - 11:40 AMBiography
Prof Matthew Naughton
Head, Sleep Service
Alfred Hospital / Monash University
Obesity and weight loss in OSA: Sleep physician point of view
11:40 AM - 12:00 PMBiography
Dr Sanjay Patel
Professor, Medicine, Epidemiology, Clinical & Translational Science
University of Pittsburgh
Should GLP-1 agonists be first line therapy in obese OSA patients?
12:00 PM - 12:20 PMBiography
Prof Ron Grunstein
Professor
The Woolcock Institute of Medical Research
Panel discussion with all speakers
12:20 PM - 12:30 PMBiography
Brendon Yee
Royal Prince Alfred Hospital/Woolcock Institute of Medical Research and Sydney University
Chair
Biography
Craig Phillips
Chair
Biography
